rs369756092
- chr16-46660189-G-GTTTTTT
- chr16-46660189-G-GTTTTTTT
- chr16-46660189-G-GT
- chr16-46660189-G-GTT
- chr16-46660189-G-GTTTC
- chr16-46660189-G-GTTT
- chr16-46660189-G-GTTTT
- chr16-46660189-G-GTTTTT
- chr16-46660189-G-GTTTTTTTT
- chr16-46660189-G-GTTTTTTTTT
- chr16-46660189-G-GTTTTTTTTTT
- chr16-46660189-G-GTTTTTTTTTTT
- chr16-46660189-G-GTTTTTTTTTTTT
- chr16-46660189-G-GTTTTTTTTTTTTT
- chr16-46660189-G-GTTTTTTTTTTTTTT
- chr16-46660189-G-GTTTTTTTTTTTTTTT
- chr16-46660189-G-GTTTTTTTTTTTTTTTT
- chr16-46660189-G-GTTTTTTTTTTTTTTTTT
- chr16-46660189-G-GTTTTTTTTTTTTTTTTTTTTT
- chr16-46660189-G-GTTTTTTTTTTTTTTTTTTTTTT
- chr16-46660189-G-GTTTTTTTTTTTTTTTTTTTTTTT
- chr16-46660189-G-GTTTTTTTTTTTTTTTTTTTTTTTT
- chr16-46660189-G-GTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr16-46660189-G-GTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr16-46660189-G-GTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr16-46660189-G-GTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr16-46660189-G-GTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr16-46660189-G-GTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr16-46660189-G-GTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr16-46660189-G-GTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr16-46660189-G-GTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr16-46660189-G-GTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr16-46660189-G-GTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr16-46660189-G-GTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr16-46660189-G-GTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1
The NM_018206.6(VPS35):c.*282_*283insAA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_018206.6 3_prime_UTR
Scores
Clinical Significance
Conservation
Publications
- Parkinson diseaseInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- Parkinson disease 17Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
- hereditary late onset Parkinson diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- intellectual disabilityInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_018206.6. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| VPS35 | TSL:1 MANE Select | c.*282_*283insAA | 3_prime_UTR | Exon 17 of 17 | ENSP00000299138.7 | Q96QK1 | |||
| VPS35 | TSL:1 | n.*3343_*3344insAA | non_coding_transcript_exon | Exon 17 of 17 | ENSP00000456274.2 | H3BRJ7 | |||
| VPS35 | TSL:1 | n.*3343_*3344insAA | 3_prime_UTR | Exon 17 of 17 | ENSP00000456274.2 | H3BRJ7 |
Frequencies
GnomAD3 genomes AF: 0.0849 AC: 7617AN: 89758Hom.: 710 Cov.: 0 show subpopulations
GnomAD4 exome AF: 0.0842 AC: 720AN: 8548Hom.: 295 Cov.: 0 AF XY: 0.0855 AC XY: 375AN XY: 4384 show subpopulations
Age Distribution
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0849 AC: 7619AN: 89772Hom.: 713 Cov.: 0 AF XY: 0.0809 AC XY: 3240AN XY: 40026 show subpopulations
Age Distribution
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.